Search
for
Sort by
Research 751–780 of 1000+
- Food and medicine homology: a potential nutritional intervention strategy for post-acute COVID-19 syndrome
- Identification of xenobiotics interfering with 5 <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="d1e152" altimg="si21.svg"> <mml:mi>α</mml:mi> </mml:math> -reductase (SRD5A2) activity
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- Comparison of Safety and Efficacy of Topical Mometasone 0.1% Ointment, Calcipotriol 0.005% Ointment, and Tacrolimus 0.1% Ointment in Patients with Localized Alopecia Areata: A Triple-Arm Randomized Clinical Study
- Distinct tooth regeneration systems deploy a conserved battery of genes
- Caffeic acid N-[3,5-bis(trifluoromethyl)phenyl] amide as a non-steroidal inhibitor for steroid 5α-reductase type 1 using a human keratinocyte cell-based assay and molecular dynamics
- Clinical and analytical evaluation of LC-MS methods for plasma renin activity and aldosterone
- LC-APCI+-MS/MS method for the analysis of ten hormones and two endocannabinoids in plasma and hair from the mice with different gut microbiota
- Alopecia areata treatment with baricitinib: different relapse phenotypes
- Improvement in health‐related quality of life and symptoms of anxiety and depression in patients with alopecia areata randomized to baricitinib or placebo: Results from two international randomized controlled trials
- Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients.
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
- Chemical Constituents of Halophyte Suaeda glauca and Their Therapeutic Potential for Hair Loss
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Dietary Habits in Japanese Patients with Alopecia Areata
- Granulomatous Alopecia Areata: A Rare Report With a Review
- Characterizing Loss of Response Occurring in a Small Number of Patients During 3 Years of Long-Term Maintenance Therapy with Baricitinib 4-mg: Results From BRAVE-AA1 and -AA2 Trials
- An integrated model of alopecia areata biomarkers highlights both TH1 and TH2 upregulation
- Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences
- Semidominant Inheritance in Epidermolytic Ichthyosis
- Evaluation of platelet-rich plasma on hair regrowth and lesional T-cell cytokine expression in alopecia areata: A randomized observer-blinded, placebo-controlled, split-head pilot study
- A Case of Alopecia Totalis with Lichen Planus Hypertrophicus Responded Excellently to Oral Tofacitinib-An Observation
- Rapid Characterization of the Functional and Pharmacological Consequences of Cantú Syndrome K<sub>ATP</sub>Channel Mutations in Intact Cells
- Abrocitinib Treatment in Diffuse Alopecia Areata: A Case Report and a Literature Review
- Assessing a measure for Quality of Life in patients with severe Alopecia Areata: a multicentric Italian study
- Upadacitinib for management of alopecia areata and rheumatoid arthritis: Letter to the editor
- La FDA aprueba Litfulo® (ritlecitinib) para el tratamiento de la alopecia areata grave en adolescentes y adultos
- Investigating the mechanisms underlying effects of testosterone on blood pressure in normotensive and hypertensive rats / Loh Su Yi
- Faculty Opinions recommendation of Targeted skin overexpression of the mineralocorticoid receptor in mice causes epidermal atrophy, premature skin barrier formation, eye abnormalities, and alopecia.
- Dupilumab in Inflammatory Skin Diseases: A Systematic Review